术中持续输注艾司氯胺酮对腹腔镜结直肠癌手术患者术后睡眠质量的影响

doi:10.3877/cma.j.issn.1674-0793.2023.06.002

目的

评价术中持续小剂量输注艾司氯胺酮对腹腔镜结直肠癌手术患者术后睡眠质量的影响。

方法

选择2023年1月至6月中南大学湘雅医学院附属常德医院择期行腹腔镜结直肠癌根治术患者80例，年龄18~65岁，ASA Ⅰ~Ⅲ级，采用随机数字表法分为艾司氯胺酮组（E组）和对照组（C组），各40例。E组在诱导插管后开始持续输注艾司氯胺酮0.2 mg·kg^-1·h^-1至手术结束，C组输注等容积0.9%氯化钠溶液，其他麻醉用药、手术方案及术后处理相同。术前1 d（D_-1）和术后第1天（D₁）、第7天（D₇）早晨采用匹兹堡睡眠质量指数量表评分（PSQI）和抑郁自评量表（SDS）评估患者睡眠质量和抑郁情况；术前2晚（D_-2）、术后当晚（D₀）、术后第6晚（D₆）佩戴运动手表，D₆行多导睡眠图，记录睡眠结构情况。记录患者手术一般资料及D₁、D₂、D₃的NRS疼痛评分。

结果

与C组相比，E组PSQI和SDS评分在D₁ （t=5.528、4.517，P<0.001、<0.001）、D₇（t=4.162、2.976，P<0.001、0.031）较低，E组在D₀、D₆时睡眠时间较长（t=5.185、4.662，P<0.001、<0.001），睡眠效率较高（t=4.485、2.717，P<0.001、0.041），入睡后觉醒时间较短（t=3.852、3.906，P=0.003、<0.001），D₀时入睡潜伏期较短（t=5.586，P<0.001），D₁时NRS疼痛评分较低（t=4.112，P<0.001），D₁、D₂镇痛泵按压次数（χ²=5.168、4.926，P<0.001、<0.001）和补救镇痛例数较少（χ²=2.558、3.887，P=0.041、<0.001），术中瑞芬太尼用量较少，差异均有统计学意义（t=3.262，P=0.011）。

结论

术中持续小剂量输注艾司氯胺酮可改善腹腔镜结直肠癌手术患者术后睡眠质量，促进患者术后快速康复。

关键词: 艾司氯胺酮, 腹腔镜, 结直肠肿瘤手术, 术后睡眠障碍

Objective

To evaluate the effect of continuous low-dose intravenous infusion of esketamine on postoperative sleep quality of patients undergoing laparoscopic colorectal cancer surgery.

Methods

Eighty patients (18-65 years old, ASAⅠ-Ⅲ) undergoing laparoscopic radical resection of colorectal cancer in Changde Hospital, Xiangya School of Medicine were randomly divided into the esketamine group (E group) and the control group (C group), with 40 cases in each group. After induction and intubation, group E were continuously infused 0.2 mg·kg^-1·h^-1 of esketamine until the end of the operation. Group C were infused with 0.9% physiological saline of the same volume. Other anesthetic drugs, surgical procedures and postoperative treatment were the same. Pittsburgh Sleep Quality Index (PSQI) and Self Rating Depression Scale (SDS) were used to assess the patients’ sleep quality and depression on the first day before operation (D_-1), the first day after operation (D₁), and the morning of the 7th day (D₇). Wearing a sports watch 2 nights before surgery (D_-2), the same night after surgery (D₀), and the 6th night after surgery (D₆), a polysomnography was performed at D₆ to record the sleep structure from 22:00 to 6:00 the next day. The patients’ general surgical information and postoperative NRS pain scores on the 1st (D₁), 2nd (D₂), and 3 (D₃) day were recorded.

Results

Compared with Group C, Group E had lower PSQI and SDS scores at D₁ (t=5.528, 4.517, P<0.001, <0.001) and D₇ (t=4.162, 2.976, P<0.001, 0.031), while Group E had longer sleep time (t=5.185, 4.662, P<0.001, <0.001), higher sleep efficiency (t=4.485, 2.717, P<0.001, 0.041), and shorter awakening time after falling asleep (t=3.852, 3.906, P=0.003, <0.001) at D₀ and D₆. The latency for falling asleep (t=5.586, P<0.001) at D₀ was shorter, and the NRS pain score was lower at D₁ (t=4.112, P<0.001). The number of D₁, D₂ analgesic pump compressions (χ²=5.168, 4.926, P<0.001, <0.001) and cases of rescue analgesia (χ²=2.558, 3.887, P=0.041, <0.001) were fewer. The amount of remifentanil used during surgery was less, and the differences were statistically significant (t=3.262, P=0.011).

Conclusion

Continuous low-dose infusion of esketamine during operation can improve the sleep quality of patients undergoing laparoscopic colorectal cancer surgery, and promote the rapid recovery of patients after surgery.

Key words: Esketamine, Laparoscopy, Colorectal cancer surgery, Postoperative sleep disturbances

表1 两组行腹腔镜结直肠癌手术患者一般资料比较（±s，t检验）

组别	例数	年龄(岁)	体质指数(kg/m²)	手术时间(min)	麻醉时间(min)	苏醒时间(min)	丙泊酚用量(mg)	舒芬太尼用量(μg)	瑞芬太尼用量(μg)
E组	39	67.25±7.17	24.53±4.92	153.6±32.8	181.7±48.5	25.82±8.63	1 036.2±122.7	65.8±8.9	752.5±105.3
C组	38	65.82±6.73	25.02±5.13	145.9±35.7	175.6±46.2	28.11±8.92	998.6±117.5	68.2±10.1	1 348.1±216.5
t值		0.512	0.428	0.572	0.533	0.596	0.615	0.527	3.262
P值		0.653	0.703	0.624	0.638	0.612	0.572	0.641	0.011

表1 两组行腹腔镜结直肠癌手术患者一般资料比较（±s，t检验）

组别	例数	年龄(岁)	体质指数(kg/m²)	手术时间(min)	麻醉时间(min)	苏醒时间(min)	丙泊酚用量(mg)	舒芬太尼用量(μg)	瑞芬太尼用量(μg)
E组	39	67.25±7.17	24.53±4.92	153.6±32.8	181.7±48.5	25.82±8.63	1 036.2±122.7	65.8±8.9	752.5±105.3
C组	38	65.82±6.73	25.02±5.13	145.9±35.7	175.6±46.2	28.11±8.92	998.6±117.5	68.2±10.1	1 348.1±216.5
t值		0.512	0.428	0.572	0.533	0.596	0.615	0.527	3.262
P值		0.653	0.703	0.624	0.638	0.612	0.572	0.641	0.011

表2 两组行腹腔镜结直肠癌手术患者不同时间点PSQI和SDS评分的比较（分，±s，t检验）

组别	例数	PSQI评分			SDS评分
组别	例数	D_-1	D₁	D₇	D_-1	D₁	D₇
E组	39	6.12±2.53	12.37±4.21^ab	9.25±3.85^ab	35.72±8.62	55.45±11.37^ab	43.61±9.85^ab
C组	38	5.98±2.59	16.85±5.19^a	11.57±3.65^a	37.33±8.51	66.39±14.25^a	50.52±10.35^a
t值		0.375	5.528	4.162	0.521	4.517	2.976
P值		0.822	<0.001	<0.001	0.649	<0.001	0.031

表2 两组行腹腔镜结直肠癌手术患者不同时间点PSQI和SDS评分的比较（分，±s，t检验）

组别	例数	PSQI评分			SDS评分
组别	例数	D_-1	D₁	D₇	D_-1	D₁	D₇
E组	39	6.12±2.53	12.37±4.21^ab	9.25±3.85^ab	35.72±8.62	55.45±11.37^ab	43.61±9.85^ab
C组	38	5.98±2.59	16.85±5.19^a	11.57±3.65^a	37.33±8.51	66.39±14.25^a	50.52±10.35^a
t值		0.375	5.528	4.162	0.521	4.517	2.976
P值		0.822	<0.001	<0.001	0.649	<0.001	0.031

表3 两组行腹腔镜下结直肠癌手术患者睡眠结构比较（±s，t检验）

组别	睡眠时间(min)			睡眠效率(%)			入睡潜伏期(min)			入睡后觉醒时间(min)
组别	D_-2	D₀	D₆	D_-2	D₀	D₆	D_-2	D₀	D₆	D_-2	D₀	D₆
E组(39例)	415.2±21.2	313.6±33.5^ab	432.3±31.6^b	86.2±5.6	65.6±6.9^ab	89.2±7.3^b	21.6±5.2	33.5±7.9^ab	18.7±5.6	42.6±8.3	133.7±19.5^ab	30.1±7.6^b
C组(38例)	421.3±25.6	250.7±22.8^a	389.7±28.2^a	87.5±5.9	52.3±6.3^a	81.1±6.7^a	19.8±4.6	42.2±10.1^a	21.3±7.1	39.8±7.8	187.3±25.6^a	69.3±11.5^a
t值	0.452	5.185	4.662	0.276	4.485	2.717	0.386	5.586	0.596	0.621	3.852	3.906
P值	0.713	<0.001	<0.001	0.885	<0.001	0.041	0.752	<0.001	0.475	0.462	0.003	<0.001

表3 两组行腹腔镜下结直肠癌手术患者睡眠结构比较（±s，t检验）

组别	睡眠时间(min)			睡眠效率(%)			入睡潜伏期(min)			入睡后觉醒时间(min)
组别	D_-2	D₀	D₆	D_-2	D₀	D₆	D_-2	D₀	D₆	D_-2	D₀	D₆
E组(39例)	415.2±21.2	313.6±33.5^ab	432.3±31.6^b	86.2±5.6	65.6±6.9^ab	89.2±7.3^b	21.6±5.2	33.5±7.9^ab	18.7±5.6	42.6±8.3	133.7±19.5^ab	30.1±7.6^b
C组(38例)	421.3±25.6	250.7±22.8^a	389.7±28.2^a	87.5±5.9	52.3±6.3^a	81.1±6.7^a	19.8±4.6	42.2±10.1^a	21.3±7.1	39.8±7.8	187.3±25.6^a	69.3±11.5^a
t值	0.452	5.185	4.662	0.276	4.485	2.717	0.386	5.586	0.596	0.621	3.852	3.906
P值	0.713	<0.001	<0.001	0.885	<0.001	0.041	0.752	<0.001	0.475	0.462	0.003	<0.001

表4 两组行腹腔镜结直肠癌手术患者D₆多导睡眠图比较（±s，t检验）

组别	例数	睡眠时间(min)	睡眠效率(%)	入睡潜伏期(min)	入睡后觉醒时间(min)
E组	39	434.1±32.2^a	89.5±7.4^a	18.2±5.5	28.2±7.4^a
C组	38	390.5±28.7	81.5±7.2	20.9±6.9	68.5±11.2
t值		4.623	2.695	0.579	3.879
P值		<0.001	0.042	0.502	<0.001

表4 两组行腹腔镜结直肠癌手术患者D₆多导睡眠图比较（±s，t检验）

组别	例数	睡眠时间(min)	睡眠效率(%)	入睡潜伏期(min)	入睡后觉醒时间(min)
E组	39	434.1±32.2^a	89.5±7.4^a	18.2±5.5	28.2±7.4^a
C组	38	390.5±28.7	81.5±7.2	20.9±6.9	68.5±11.2
t值		4.623	2.695	0.579	3.879
P值		<0.001	0.042	0.502	<0.001

表5 两组行腹腔镜结直肠癌手术患者术后疼痛情况比较

组别	例数	NRS疼痛评分(分)			镇痛泵按压次数			补救镇痛（例）
组别	例数	D₁	D₂	D₃	D₁	D₂	D₃	D₁	D₂	D₃
E组	39	3.78±1.35^ab	3.22±1.14^a	2.71±0.95^a	31^b	22^b	8	5^b	1^b	0
C组	38	4.59±1.77	3.59±1.17	3.05±1.06	61	45	13	12	6	2
统计值		4.112	0.525	0.489	5.168	4.926	0.756	2.558	3.887	0.635
P值		<0.001	0.498	0.521	<0.001	<0.001	0.285	0.041	<0.001	0.452

表5 两组行腹腔镜结直肠癌手术患者术后疼痛情况比较

组别	例数	NRS疼痛评分(分)			镇痛泵按压次数			补救镇痛（例）
组别	例数	D₁	D₂	D₃	D₁	D₂	D₃	D₁	D₂	D₃
E组	39	3.78±1.35^ab	3.22±1.14^a	2.71±0.95^a	31^b	22^b	8	5^b	1^b	0
C组	38	4.59±1.77	3.59±1.17	3.05±1.06	61	45	13	12	6	2
统计值		4.112	0.525	0.489	5.168	4.926	0.756	2.558	3.887	0.635
P值		<0.001	0.498	0.521	<0.001	<0.001	0.285	0.041	<0.001	0.452

表6 两组行腹腔镜结直肠癌手术患者术后不良反应比较（例，χ²检验）

组别	例数	呼吸抑制	恶心	呕吐	头痛
E组	39	1	11	6	1
C组	38	2	9	5	0
χ²值		0.217	0.312	0.186	0.285
P值		0.855	0.758	0.896	0.811

表6 两组行腹腔镜结直肠癌手术患者术后不良反应比较（例，χ²检验）

组别	例数	呼吸抑制	恶心	呕吐	头痛
E组	39	1	11	6	1
C组	38	2	9	5	0
χ²值		0.217	0.312	0.186	0.285
P值		0.855	0.758	0.896	0.811

[1]	David RH. Postoperative sleep disturbances: understanding and emerging therapies[J]. Adv Anesth, 2017, 35(1): 1-24.
[2]	Mitsuru I, Hiroki O, Motoo Y, et al. Preoperative sleep disruption and postoperative functional disability in lung surgery patients: A prospective observational study[J]. J Anesth, 2019, 33(4): 501-508.
[3]	Eberl S, Koers L, van Hooft J, et al. The effectiveness of a low-dose esketamine versus an alfentanil adjunct to propofol sedation during endoscopic retrograde cholangiopancreatography: A randomised controlled multicentre trial[J]. Eur J Anaesthesiol, 2020, 37(5): 394-401.
[4]	Bahji A, Vazquez GH, Zarate CA Jr. Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis[J]. J Affect Disord, 2021, 278(1): 542-555.
[5]	Song BJ, Zhu JC. A novel application of ketamine for improving perioperative sleep disturbances[J]. Nat Sci Sleep, 2021, 13(12): 2251-2266.
[6]	Wang CS, Kavalali ET, Monteggia LM. BDNF signaling in context: from synaptic regulation to psychiatric disorders[J]. Cell, 2022, 185(1): 62-76.
[7]	Kriengtuntiwong T, Zaw YH, Taneepanichskul N. Brain-derived neurotrophic factor (BDNF) depression and subjective sleep quality in the first trimester of pregnancy among migrant workers in Thailand[J]. J Multidiscip Healthc, 2021, 14(9): 2549-2566.
[8]	Wang MQ, Zhang B, Zhou YL, et al. Sleep improvement is associated with the antidepressant efficacy of repeated-dose ketamine and serum BDNF levels: A post-hoc analysis[J]. Pharmacol Rep, 2021, 73(2): 594-603.
[9]	Lei YS, Liu HY, Xia F, et al. Effects of esketamine on acute and chronic pain after thoracoscopy pulmonary surgery under general anesthesia: A multicenter-prospective, randomized, double-blind, and controlled trial[J]. Front Med (Lausanne), 2021, 8(9): 693594.
[10]	Wang Y, Zhang Q, Dai X, et al. Effect of low-dose esketamine on pain control and postpartum depression after cesarean section: A retrospective cohort study[J]. Ann Palliat Med, 2022, 11(1): 45-57.

[1]	李国新, 陈新华. 全腹腔镜下全胃切除术食管空肠吻合的临床研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 1-4.
[2]	李子禹, 卢信星, 李双喜, 陕飞. 食管胃结合部腺癌腹腔镜手术重建方式的选择[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 5-8.
[3]	李乐平, 张荣华, 商亮. 腹腔镜食管胃结合部腺癌根治淋巴结清扫策略[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 9-12.
[4]	陈方鹏, 杨大伟, 金从稳. 腹腔镜近端胃癌切除术联合改良食管胃吻合术重建His角对术后反流性食管炎的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 15-18.
[5]	许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[6]	李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[7]	任佳, 马胜辉, 王馨, 石秀霞, 蔡淑云. 腹腔镜全胃切除、间置空肠代胃术的临床观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 31-34.
[8]	赵丽霞, 王春霞, 陈一锋, 胡东平, 张维胜, 王涛, 张洪来. 内脏型肥胖对腹腔镜直肠癌根治术后早期并发症的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 35-39.
[9]	李博, 贾蓬勃, 李栋, 李小庆. ERCP与LCBDE治疗胆总管结石继发急性重症胆管炎的效果[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 60-63.
[10]	韩戟, 杨力, 陈玉. 腹部形态CT参数与完全腹腔镜全胃切除术术中失血量的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 88-91.
[11]	王露, 周丽君. 全腹腔镜下远端胃大部切除不同吻合方式对胃癌患者胃功能恢复、并发症发生率的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 92-95.
[12]	冯旺, 马振中, 汤林花. CT扫描三维重建在肝内胆管细胞癌腹腔镜肝切除术中的临床研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 104-107.
[13]	王庆亮, 党兮, 师凯, 刘波. 腹腔镜联合胆道子镜经胆囊管胆总管探查取石术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 313-313.
[14]	杨建辉, 段文斌, 马忠志, 卿宇豪. 腹腔镜下脾部分切除术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 314-314.
[15]	叶劲松, 刘驳强, 柳胜君, 吴浩然. 腹腔镜肝Ⅶ+Ⅷ段背侧段切除[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 315-315.

阅读次数

全文

摘要

选择文件类型/文献管理软件名称

选择包含的内容

Effect of continuous infusion of esketamine on postoperative sleep quality of patients undergoing laparoscopic colorectal cancer surgery

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

Effect of continuous infusion of esketamine on postoperative sleep quality of patients undergoing laparoscopic colorectal cancer surgery